They are also consistent with a study of oropharyngeal squamous cell carcinoma (OSCC), in which LOX expression was shown to be an independent prognostic biomarker predictive of lymph node metastasis [2]. The gene discussed is LOX; the disease is oropharynx squamous cell carcinoma.